Trial Profile
Efficacy and safety of DPP-4 inhibitors in diabetic patients undergoing hemodialysis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Feb 2017
Price :
$35
*
At a glance
- Drugs Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Feb 2017 New trial record